[1] |
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3):209-249.
|
[2] |
Zhang B, Zhang B, Zhang Z, et al. 42,573 cases of hepatectomy in China: a multicenter retrospective investigation[J]. Sci China Life Sci, 2018, 61(6):660-670.
|
[3] |
European Association for the Study of the Liver. EASL clinical practice guidelines: management of hepatocellular carcinoma[J].J Hepatol, 2018, 69(1):182-236.
|
[4] |
Omata M, Cheng AL, Kokudo N, et al. Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update[J]. Hepatol Int, 2017, 11(4):317-370.
|
[5] |
Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2):115-132.
|
[6] |
中华人民共和国国家卫生健康委员会医政医管局. 原发性肝癌诊疗指南(2022年版)[J]. 中华消化外科杂志, 2022, 21(2):143-168.
|
[7] |
Tiyarattanachai T, Apiparakoon T, Marukatat S, et al. Development and validation of artificial intelligence to detect and diagnose liver lesions from ultrasound images[J]. PLoS One, 2021, 16(6): e0252882.
|
[8] |
Marya NB, Powers PD, Fujii-Lau L, et al. Application of artificial intelligence using a novel EUS-based convolutional neural network model to identify and distinguish benign and malignant hepatic masses[J]. Gastrointest Endosc, 2021, 93(5):1121-1130, e1.
|
[9] |
Fan R, Papatheodoridis G, Sun J, et al. aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis[J]. J Hepatol, 2020, 73(6):1368-1378.
|
[10] |
Ioannou GN, Tang W, Beste LA, et al. Assessment of a deep learning model to predict hepatocellular carcinoma in patients with hepatitis C cirrhosis[J]. JAMA Netw Open, 2020, 3(9):e2015626.
|
[11] |
刘景丰, 刘红枝, 陈振伟, 等. 肝病和肝癌大数据平台建设体系及其初步应用[J]. 中华消化外科杂志, 2021, 20(1):46-51.
|
[12] |
Ardila D, Kiraly AP, Bharadwaj S, et al. End-to-end lung cancer screening with three-dimensional deep learning on low-dose chest computed tomography[J]. Nat Med, 2019, 25(6):954-961.
|
[13] |
Misawa M, Kudo SE, Mori Y, et al. Artificial intelligence-assisted polyp detection for colonoscopy: initial experience[J]. Gastroenterology, 2018, 154(8):2027-2029, e3.
|
[14] |
Bi WL, Hosny A, Schabath MB, et al. Artificial intelligence in cancer imaging: clinical challenges and applications[J]. CA Cancer J Clin, 2019, 69(2):127-157.
|
[15] |
Zhou J, Wang W, Lei B, et al. Automatic detection and classification of focal liver lesions based on deep convolutional neural networks: a preliminary study[J]. Front Oncol, 2021(10): 581210.
|
[16] |
Hamm CA, Wang CJ, Savic LJ, et al. Deep learning for liver tumor diagnosis partⅠ: development of a convolutional neural network classifier for multi-phasic MRI[J]. Eur Radiol, 2019, 29(7):3338-3347.
|
[17] |
Wu Y, White GM, Cornelius T, et al. Deep learning LI-RADS grading system based on contrast enhanced multiphase MRI for differentiation between LR-3 and LR-4/LR-5 liver tumors[J]. Ann Transl Med, 2020, 8(11):701.
|
[18] |
Kondo S, Takagi K, Nishida M, et al. Computer-aided diagnosis of focal liver lesions using contrast-enhanced ultrasonography with perflubutane microbubbles[J]. IEEE Trans Med Imaging, 2017, 36(7):1427-1437.
|
[19] |
Le Berre C, Sandborn WJ, Aridhi S, et al. Application of artificial intelligence to gastroenterology and hepatology[J]. Gastroenterology, 2020, 158(1):76-94, e2.
|
[20] |
Wang CJ, Hamm CA, Savic LJ, et al. Deep learning for liver tumor diagnosis partⅡ: convolutional neural network interpretation using radiologic imaging features[J]. Eur Radiol, 2019, 29(7):3348-3357.
|
[21] |
Robertson S, Azizpour H, Smith K, et al. Digital image analysis in breast pathology-from image processing techniques to artificial intelligence[J]. Transl Res, 2018(194):19-35.
|
[22] |
William W, Ware A, Basaza-Ejiri AH, et al. A review of image analysis and machine learning techniques for automated cervical cancer screening from pap-smear images[J]. Comput Methods Programs Biomed, 2018(164):15-22.
|
[23] |
Sharma H, Zerbe N, Klempert I, et al. Deep convolutional neural networks for automatic classification of gastric carcinoma using whole slide images in digital histopathology[J]. Comput Med Imaging Graph, 2017(61):2-13.
|
[24] |
Ayyad SM, Shehata M, Shalaby A, et al. Role of AI and histopathological images in detecting prostate cancer: a survey[J]. Sensors, 2021, 21(8):2586.
|
[25] |
Wang X, Fang Y, Yang S, et al. A hybrid network for automatic hepatocellular carcinoma segmentation in H&E-stained whole slide images[J]. Med Image Anal, 2021(68):101914.
|
[26] |
Roy M, Kong J, Kashyap S, et al. Convolutional autoencoder based model HistoCAE for segmentation of viable tumor regions in liver whole-slide images[J]. Sci Rep, 2021, 11(1):139.
|
[27] |
Liao H, Long Y, Han R, et al. Deep learning-based classification and mutation prediction from histopathological images of hepatocellular carcinoma[J]. Clin Transl Med, 2020, 10(2):e102.
|
[28] |
Kiani A, Uyumazturk B, Rajpurkar P, et al. Impact of a deep learning assistant on the histopathologic classification of liver cancer[J]. NPJ Digit Med, 2020(3):23.
|
[29] |
Chen W, Zhang T, Xu L, et al. Radiomics analysis of contrast-enhanced CT for hepatocellular carcinoma grading[J]. Front Oncol, 2021(11):660509.
|
[30] |
Zhou W, Wang G, Xie G, et al. Grading of hepatocellular carcinoma based on diffusion weighted images with multiple b-values using convolutional neural networks[J]. Med Phys, 2019, 46(9):3951-3960.
|
[31] |
Wang K, Lu X, Zhou H, et al. Deep learning Radiomics of shear wave elastography significantly improved diagnostic performance for assessing liver fibrosis in chronic hepatitis B: a prospective multicentre study[J]. Gut, 2019, 68(4):729-741.
|
[32] |
Gu D, Xie Y, Wei J, et al. MRI-based radiomics signature: a potential biomarker for identifying glypican 3-positive hepatocellular carcinoma[J]. J Magn Reson Imaging, 2020, 52(6):1679-1687.
|
[33] |
Wang W, Gu D, Wei J, et al. A radiomics-based biomarker for cytokeratin 19 status of hepatocellular carcinoma with gadoxetic acid-enhanced MRI[J]. Eur Radiol, 2020, 30(5):3004-3014.
|
[34] |
刘红枝, 林海涛, 林昭旺, 等. 机器学习算法在肝细胞癌微血管侵犯术前预测中的应用价值[J]. 中华消化外科杂志, 2020, 19(2):156-165.
|
[35] |
Chen G, Wang R, Zhang C, et al. Integration of pre-surgical blood test results predict microvascular invasion risk in hepatocellular carcinoma[J]. Comput Struct Biotechnol J, 2021(19):826-834.
|
[36] |
Jiang YQ, Cao SE, Cao S, et al. Preoperative identification of microvascular invasion in hepatocellular carcinoma by XGBoost and deep learning[J]. J Cancer Res Clin Oncol, 2021, 147(3):821-833.
|
[37] |
Zhou W, Jian W, Cen X, et al. Prediction of microvascular invasion of hepatocellular carcinoma based on contrast-enhanced MR and 3D convolutional neural networks[J]. Front Oncol, 2021(11):588010.
|
[38] |
Chen S, Feng S, Wei J, et al. Pretreatment prediction of immunoscore in hepatocellular cancer: a radiomics-based clinical model based on Gd-EOB-DTPA-enhanced MRI imaging[J]. Eur Radiol, 2019, 29(8):4177-4187.
|